The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarker-driven access to crizotinib in ALK, MET, or ROS1 positive (+) malignancies in adults and children: The French National AcSé Program.
 
Gilles Vassal
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Nathalie Cozic
No Relationships to Disclose
 
Gilbert Ferretti
No Relationships to Disclose
 
Sophie Taieb
Travel, Accommodations, Expenses - Guerbet
 
Roch Houot
No Relationships to Disclose
 
Laurence Brugieres
No Relationships to Disclose
 
Thomas Aparicio
Honoraria - Amgen; Bristol-Myers Squibb; Léo Pharma; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; HalioDx; Ipsen; MSD Oncology; Pierre Fabre
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Hospira; Ipsen; Ipsen; Novartis; Roche
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma
 
Ivan Bieche
No Relationships to Disclose
 
Sylvie Lantuejoul
No Relationships to Disclose
 
Celine Mahier - Ait Oukhatar
No Relationships to Disclose
 
Natalie Hoog Labouret
No Relationships to Disclose
 
Denis Moro-Sibilot
No Relationships to Disclose